Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Physiol Res ; 66(Suppl 1): S85-S90, 2017 04 05.
Article in English | MEDLINE | ID: mdl-28379033

ABSTRACT

This article describes the evolution of our understanding of familial hypercholesterolemia (FH) in the Central, Eastern, and Southern Europe (CESE) region, and the dissemination of this understanding to other countries. Using the ScreenPro FH project as an example, we would like to illustrate the progression from national objectives, to regional networking and, finally, to international collaboration via the Familial Hypercholesterolemia Studies Collaboration (FHSC) project under the leadership of the European Atherosclerosis Society (EAS). It is essential to improve our ability to diagnose FH. In this regard, the EAS and its FHSC project must be commended for their educational and organizational activities which, above all, are dedicated to the creation of a global FH patient registry. In the CESE region, FH diagnostics and treatment situation are markedly different than in Western Europe or North America. Since the Czech MedPed project (Make Early Diagnoses to Prevent Early Deaths in Medical Pedigrees) has been so successful (with results not only comparable to, but, for some parameters, even surpassing the results of many Western countries) we decided to apply the Czech experience to the CESE region. Thus, the ScreenPro FH project was created. The aim of ScreenPro FH is to create a specialist network in the CESE region. The primary objective of the ScreenPro FH project was to dramatically reduce the number of premature deaths due to clinical complications of atherosclerosis in FH patients. At present, ScreenPro FH comprises 18 member countries with a total population of 500,000,000; which, in terms of the FH population, represents 1-2 million patients.


Subject(s)
Hyperlipoproteinemia Type II/diagnosis , Hyperlipoproteinemia Type II/epidemiology , International Cooperation , Mass Screening/methods , Societies, Medical , Atherosclerosis/diagnosis , Atherosclerosis/epidemiology , Czech Republic/epidemiology , Early Diagnosis , Europe/epidemiology , Humans , Mass Screening/trends
2.
Article in English | MEDLINE | ID: mdl-19760527

ABSTRACT

Residues of printing ink components were determined in 94 samples of packaging materials commercially used in the Czech Republic for food packaging. The samples tested included printed polyethylene and polypropylene films, co-extruded and laminated films, paperboard beverages boxes, foils for thermo sealing of polystyrene cups, and polypropylene cups. Printing ink components were extracted with diethylether, then separated and determined using gas chromatography-mass spectrometry (GC/MS). Fifty compounds potentially originating from printing were isolated, identified and quantified. No acute health risk for consumers were identified, even though several findings of high levels of photo-initiators (e.g. in polyethylene terephthalate (PET) films for thermo sealing of polystyrene cups) as well as plasticizers (acetyl tributyl citrate, tributyl aconitate, 2-butoxyethyl oleate and 2-ethylhexyl diphenyl phosphate in co-extruded films) indicate that their real migration into food and/or food simulants needs to be undertaken for a proper safety evaluation.


Subject(s)
Food Contamination/analysis , Food Packaging , Ink , Czech Republic , Gas Chromatography-Mass Spectrometry , Humans , Photochemical Processes , Plasticizers/adverse effects , Plasticizers/analysis , Polymers/adverse effects , Polymers/analysis , Risk Assessment , Solvents/adverse effects , Solvents/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...